CONTENTS:
- Achieving consensus, coherence, clarity and consistency when talking about addiction [Editorial]. West R., Cox S., Notley C.J., Du Plessis G., Hastings J., p. 796-798.
- Restricting alcohol marketing to reduce alcohol consumption: A systematic review of the empirical evidence for one of the 'best buys'. Manthey J., Jacobsen B., Klinger S., Schulte B., Rehm J., p. 799-811.
- Commentary on Manthey et al.: No more missed opportunities-We need to address the absence of robust and comprehensive evaluations about the real-world impact of statutory restrictions on alcohol marketing. Critchlow N., p. 812-814.
- Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis. Kotake K., Hosokawa T., Tanaka M., So R., Banno M., Kataoka Y., et al., p. 815-832.
- Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials. Amin-Esmaeili M., Farokhnia M., Susukida R., Leggio L., Johnson R.M., Crum R.M., et al., p. 833-843.
- Commentary on Amin-Esmaeili et al.: Non-abstinence outcomes in stimulant clinical trials - Why deny improvement? Tardelli V.S., p. 844-845.
- The effect of a minimum price per unit of alcohol in Scotland on alcohol-related ambulance call-outs: A controlled interrupted time-series analysis. Manca F., Lewsey J., Mackay D., Angus C., Fitzpatrick D., Fitzgerald N., p. 846-854.
- Quantifying alcohol-attributable disability-adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data. Casswell S., Huckle T., Romeo J.S., Moewaka Barnes H., Connor J., Rehm J., p. 855-862.
- Assessing the acceptability of implementing a Screening, Brief Intervention and Referral to Treatment for alcohol use among transgender women in Bangkok, Thailand: A mixed-method pre-implementation study using the Consolidated Framework for Implementation Research. Yimsaard P., Mootz J.J., Rungnirundorn T., Janamnuaysook R., Samitpol K., Phanuphak N., et al., p. 863-874.
- Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trial. Pesola F., Smith K.M., Phillips-Waller A., Przulj D., Griffiths C., Walton R., et al., p. 875-884.
- How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016-2020 International Tobacco Control United States surveys. He Y., Liber A., Driezen P., Thompson M.E., Levy D.T., Fong G.T., et al., p. 885-897.
- What to do after smoking relapse? A sequential multiple assignment randomized trial of chronic care smoking treatments. Schlam T.R., Baker T.B., Piper M.E., Cook J.W., Smith S.S., Zwaga D., et al., p. 898-914.
- Community Reinforcement and Family Training versus counselling for parents of treatment-refusing young adults with hazardous substance use: A randomized controlled trial. Siljeholm O., Edvardsson K., Bergström M., Hammarberg A., p. 915-927.
- Problematic pornography use across countries, genders, and sexual orientations: Insights from the International Sex Survey and comparison of different assessment tools. Bothe B., Nagy L., Koos M., Demetrovics Z., Potenza M.N., Kraus S.W., p. 928-950.
- How to apply zero-shot learning to text data in substance use research: An overview and tutorial with media data. Riordan B., Bonela A.A., He Z., Nibali A., Anderson-Luxford D., Kuntsche E., p. 951-959.
- Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022. Garel N., Tate S., Nash K., Lembke A., p. 960-964.
- Comment on Domzaridou et al.: Recognising the complexities of co-prescriptions and lifestyle factors in opioid agonist treatment. Bakker A., Smith A., Liebrenz M., p. 965-966.
- Recognizing the complexities of co-prescriptions and life-style factors in opioid agonist treatment: A response from Eleni Domzaridou, Matthew J. Carr, Tim Millar, Roger T. Webb and Darren M. Ashcroft. Domzaridou E., Carr M.J., Millar T., Webb R.T., Ashcroft D.M., p. 967-968.
- Health-care personnel and energy drinks: A new category of subjects at risk? Farinetti A., Mattioli A.V., p. 969-970.